Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 11, 1996, Pages 811-815

  Booij, A ^a   Biewenga Booij, C M ^a   Huber Bruning, O ^a   Cornelis, C ^a   Jacobs, J W G ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROGESTERONE; TESTOSTERONE PROPIONATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; WELLBEING;

EID: 0029848316     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.11.811     Document Type: Article

References (21)

1. Cutolo M, Seriolo B, Sulli A, Accardo S. Androgens in rheumatoid arthritis. In: Bijlsma JWJ, Linden S van der, Barnes CG, eds. Rheumatology highlights 1995. Rheumatol Eur 1995;24(S-2):211-4.
2. Masi AT, Feigenbaum SL, Chatterton RT. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunological and microvascular systems. Semin Arthritis Rheum 1995;25:1-27.
3. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-38.
4. Hall GM, Perry LA, Spector TD. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis, but no relation with axial bone density. Ann Rheum Dis 1993;52:211-4.
5. Araneo BA, Dowel T, Dieguel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4, IL-5 and tIFN, but not IL-2 by activated murine cells. Blood 1991;78:688-99.
6. Cutolo M, Accardo S, Villagio B, Clerico P, Indiveri F, Carruba G, et al. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992;35:1007-15.
7. Da Silva JAP, Larbre JP, Seed M, Cutolo M, Villagio B, Scott DL, et al. Sex differences in inflammation induced cartilage damage in rodents. J Rheumatol 1994;21:330-7.
8. Margolis HM, Caplan PS. The effect of some steroids in rheumatoid arthritis. Ann Intern Med 1951;34:61-71.
9. Bird HA, Burkinshaw L, Pearson D, Atkinson PJ, Leathman PA, Hill J, et al. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women. Ann Rheum Dis 1987;46:237-43.
10. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
11. Arnett FC, Edworthy SM, Block DA, McShane DJ, Frics JF, Cooper NS, et al. The American Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Boers M, Tugwell P. Outcome measures in rheumatoid arthritis clinical trials. J Rheumatol 1993;20:525-91.
13. Prevoo ML, Van't Hof MA, Kuper HH, Van leeuwen MA, Van de Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
14. Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire Capacities of Daily Life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:71-4.
15. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. Development of a self-report questionnaire to assess the impact of rheumatic diseases on health and lifestyle. J Rehabil Sci 1990;3:75-80.
16. Meenan RF, Gertman PM, Mason JM. Measuring health status in arthritis: the Arthritis Impact Measurement Scale. Arthritis Rheum 1980;23:146-53.
17. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
18. Panush RM. Nontraditional remedies. In: Schumacher RH, Klippel JH, Koopman WJ, eds. Primer on the rheumatic diseases 1993;10:323-7.
19. Brink HR van den, Lems WF, Everdingen AA van, Bijlsma JWJ. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis 1993;52:302-5.
20. Bijlsma JWJ, Brink HR van den. Estrogens and rheumatoid arthritis. Am J Reprod Immunol 1992;28:231-4.
21. Lyritís GP, Androulakis C, Magiasis B, Charalambaki Z, Tsakalakos N. Effect of nandrolone decanoate and 1α hydroxy calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial. Bone Miner Res 1994;27:209-17.